![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on January 1, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 11, 2005
Revised on September 24, 2005
Accepted on October 7, 2005
*Myogen, Westminster, CO 80021; Department of Molecular Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9148
Monitoring Editor: Marianne Bronner-Fraser
Class II histone deacetylases (HDACs) contain unique amino-terminal extensions that mediate interactions with members of the myocyte enhancer factor-2 (MEF2) family of transcription factors and responsiveness to kinases, including Ca2+/calmodulin-dependent kinase (CaMK). Despite intense investigation of class II HDACs, little is known of MEF2-independent mechanisms for transcriptional repression by these chromatin-modifying enzymes. Here, we demonstrate that class II HDACs 4 and 5 physically associate with ankyrin-repeat proteins ANKRA2 and RFXANK (RFX-B/Tvl-1/ANKRA1). ANKRA2 is a megalin- and BKCa potassium channel-interacting factor, while RFXANK is a positive regulator of major histocompatibility complex II (MHC II) gene expression. HDAC4 and HDAC5 interact with the ankyrin repeats of ANKRA2 and RFXANK and, through association with RFXANK, repress MHC II promoter activation. HDACs 4 and 5 also repress endogenous HLA-DRA gene expression induced by CIITA. Phosphorylation of class II HDACs by CaMK results in CRM1-dependent nuclear export of HDAC/RFXANK complexes. These results define a novel transcriptional pathway under the control of class II HDACs and suggest a role for these transcriptional repressors as signal-responsive regulators of antigen presentation.
These authors contributed equally to this work.
Address correspondence to:
Eric N. Olson (eolson{at}hamon.swmed.edu)
This article has been cited by other articles:
|
|
 |
|
  E. Casas and G. D. Snowder A putative quantitative trait locus on chromosome 20 associated with bovine pathogenic disease incidence J Anim Sci, October 1, 2008; 86(10): 2455 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pang, C. Yan, K. Natarajan, M. E. Cavet, M. P. Massett, G. Yin, and B. C. Berk GIT1 Mediates HDAC5 Activation by Angiotensin II in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Herrmann, R. S. Agrawal, S. F. Connolly, R. L. McCaffrey, J. Schlomann, and D. J. Kusner MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II J. Leukoc. Biol., September 1, 2007; 82(3): 686 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Pagan, J. Arnold, K. J. Hanchard, R. Kumar, T. Bruno, M. J. K. Jones, D. J. Richard, A. Forrest, A. Spurdle, E. Verdin, et al. A Novel Corepressor, BCoR-L1, Represses Transcription through an Interaction with CtBP J. Biol. Chem., May 18, 2007; 282(20): 15248 - 15257. [Abstract] [Full Text] [PDF]
|
|
